Please login to the form below

Not currently logged in
Email:
Password:

radium-223 dichloride

This page shows the latest radium-223 dichloride news and features for those working in and with pharma, biotech and healthcare.

Japanese approvals for GSK, AZ and Bayer

Japanese approvals for GSK, AZ and Bayer

Finally, Bayer has won Japanese approval for Xofigo (radium-223 dichloride, radium-223), its radiopharmaceutical drug for the treatment of patients with castration-resistant prostate cancer and bone metastases.

Latest news

  • Price cut keeps Kadcyla on CDF Price cut keeps Kadcyla on CDF

    Bayer's Xofigo (radium-223 dichloride) for castration-resistant prostate cancer with bone metastases remains under appeal.

  • Eylea growth closes the gap with Lucentis Eylea growth closes the gap with Lucentis

    Combined sales of Bayer's five growth products - Eylea, pulmonary hypertension drug Adempas (riociguat), anticoagulant Xarelto (rivaroxaban) and cancer therapies Stivarga (regorafenib) and Xofigo (radium Ra 223 dichloride) - came in at

  • Bayer's Eylea cleared for wider use in Europe Bayer's Eylea cleared for wider use in Europe

    For the full year, revenues were up 5% to 42.2bn. The company's five most recently launched drugs - Eylea; anticoagulant Xarelto (rivaroxaban); cancer drugs Stivarga (regorafenib) and Xofigo (radium Ra ... 223 dichloride); and pulmonary hypertension

  • Personalised cancer medicines showcased in BBC investigation Personalised cancer medicines showcased in BBC investigation

    Astellas and Medivation's advanced prostate cancer drug Xtandi (enzalutamide) was highlighted being used with Bayer's Xofigo (Radium Ra 223 Dichloride) for an elderly patient with late-stage prostate cancer

  • Bayer CEO Dekkers points to 'outstanding' pharma growth Bayer CEO Dekkers points to 'outstanding' pharma growth

    Prostate cancer drug Xofigo (radium-223 dichloride) also built momentum, bringing in 49m in the quarter, although Bayer will want to see a sizeable uptick in sales to offset the

More from news
Approximately 3 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics